ARTICLE | Company News
PathoGenesis sales and marketing update
May 17, 1999 7:00 AM UTC
PGNS's PathoGenesis Canada Ltd. subsidiary (Montreal, Quebec) began Canadian sales of TOBI tobramycin to manage cystic fibrosis patients with chronic Pseudomonas aeruginosa infections. ...